Molecular Biology of Tumor Cells: Present and Future
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 1301
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue will focus on the molecular biology of tumor cells. Malignant disease is a worldwide problem involving patients, their families, medical professionals, and health systems.
At the moment, we offer numerous therapies including surgery, radiation, chemotherapy, derivatives of classical therapeutics and biological drugs and many other strategies that defend against cancer cells, like miRNA, CRISPR and immune system-based drugs. Biological drugs—especially those that target de-regulated signaling cascades—can maintain long-lasting disease-free periods. Without basic studies of cancer cells on the molecular biology level, the above-mentioned progress will not be possible. Because tumor malignant cells change gradually and gain some resistant phenotypes, the further development of cancer-related studies on the molecular biology level may result in the development of knowledge through which more targeted and less harmful therapy can be offered to patients.
This Special Issue intends to showcase the current progress related to molecular biology research on tumor cells. Original research articles, review articles and short communications within (but not restricted to) the described research fields are welcome.
Dr. Izabela Mlynarczuk-Bialy
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular immunology of cancer
- ubiquitin-proteasome system in cancer
- microRNA in cancer
- extracellular matrix in cancer
- metalloproteinases
- cancer stem cells
- ROS
- molecular prognosis and diagnosis of cancer
- cancer epigenetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
